These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4953508)

  • 21. [Significance of the copiousness of bacteria excretion in newly detected patients with destructive pulmonary tuberculosis].
    Kanevskaia SS
    Probl Tuberk; 1982 Mar; (3):31-4. PubMed ID: 6806804
    [No Abstract]   [Full Text] [Related]  

  • 22. Exclusive mutations related to isoniazid and ethionamide resistance among Mycobacterium tuberculosis isolates from Korea.
    Lee H; Cho SN; Bang HE; Lee JH; Bai GH; Kim SJ; Kim JD
    Int J Tuberc Lung Dis; 2000 May; 4(5):441-7. PubMed ID: 10815738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "Dysgonic" strains of mycobacterium tuberculosis on Ogawa's egg medium isolated as pathogens from patients suffering from lung tuberculosis. I. Clinical and biological findings of "dysgonic".
    Ujiiye A; Nemoto G; Kinoshita Y
    Jpn J Tuberc; 1967 Dec; 14(3):105-15. PubMed ID: 4970395
    [No Abstract]   [Full Text] [Related]  

  • 24. [Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis].
    Mkrtchian SV; Ushkin VV
    Antibiotiki; 1971 May; 16(5):472-7. PubMed ID: 5002224
    [No Abstract]   [Full Text] [Related]  

  • 25. [Bacteriological study of 51 specimens from excisions performed for pulmonary tuberculosis between 1964 and 1968].
    Viallier J; Touraine R; Boutinet C
    J Med Lyon; 1970 Jan; 51(179):433-4 passim. PubMed ID: 5005480
    [No Abstract]   [Full Text] [Related]  

  • 26. [Drug dependance of Mycobacterium tuberculosis].
    Mel'nikov EL
    Probl Tuberk; 1969; 47(5):60-4. PubMed ID: 4983819
    [No Abstract]   [Full Text] [Related]  

  • 27. [A clinical study on the virulence of INH-resistant tubercle bacilli in the human body].
    Murata A
    Kekkaku; 1967 Aug; 42(8):309-11. PubMed ID: 4966678
    [No Abstract]   [Full Text] [Related]  

  • 28. Evolution in the resistance of Mycobacterium tuberculosis to anti-tuberculosis drugs in Nicaragua.
    Chacón L; Lainez M; Rosales E; Mercado M; Caminero JA
    Int J Tuberc Lung Dis; 2009 Jan; 13(1):62-7. PubMed ID: 19105880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates.
    Lee AS; Teo AS; Wong SY
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2157-9. PubMed ID: 11408244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Biological properties of Mycobacterium tuberculosis in relation to sensitivity to antibacterial preparations].
    Gol'shevskaia VI; Grishina TA; Karpenko OL; Safonova SG; Grishina TD
    Probl Tuberk; 1995; (4):37-40. PubMed ID: 7567869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Heterogeneity of drug-resistant strains of Mycobacterium tuberculosis].
    Belogurova VP
    Probl Tuberk; 1970; 48(9):76-9. PubMed ID: 4996497
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparison of the clinical course of tuberculosis in patients infected with INH resitans catalase positive and catalase negative strains].
    Popović J; Davidović C
    Tuberkuloza; 1968; 20(3):101-5. PubMed ID: 4987221
    [No Abstract]   [Full Text] [Related]  

  • 33. [Early results of pulmonary tissue resection for tuberculous lesions].
    Karski J; Krzywiński R; Pycz-Pyczewski M
    Pol Przegl Chir; 1971; 43(4):577-83. PubMed ID: 4996171
    [No Abstract]   [Full Text] [Related]  

  • 34. Susceptibilities of Mycobacterium tuberculosis to isoniazid and rifampin on blood agar.
    Coban AY; Bilgin K; Uzun M; Tasdelen Fisgin N; Akgunes A; Cihan CC; Birinci A; Durupinar B
    J Clin Microbiol; 2005 Apr; 43(4):1930-1. PubMed ID: 15815022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-resistant tuberculosis in Budapest.
    Fodor T; Vadász I; Lõrinczi I
    Int J Tuberc Lung Dis; 1998 Sep; 2(9):732-5. PubMed ID: 9755927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New technologies in the determination of drug susceptibility in Mycobacterium tuberculosis].
    Skotnikova OI; Mikhaĭlovich VM; Nosova EIu; Lapa SA; Griadunov DA; Donnikov MIu; Badleeva MV; Galkina KIu; Dorozhkova IR; Litvinov VI; Zasedatelev AS; Moroz AM; Mirzabekov AD
    Probl Tuberk Bolezn Legk; 2004; (6):40-2. PubMed ID: 15315132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Studies on the infection of drug-resistant tubercle bacilli. 3. Experimental studies on the infection of INH highly-resistant tubercle bacilli].
    Osato T; Toyohara M; Aoki M; Hatori H
    Kekkaku; 1968 Nov; 43(11):473-9. PubMed ID: 4975533
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of drug resistance of Mycobacterium tuberculosis on the therapeutic results of a drug to which sensitivity is retained(experimental data)].
    Belogurova VP; Ivanitskaia NN
    Antibiotiki; 1970 Feb; 15(2):154-7. PubMed ID: 4986204
    [No Abstract]   [Full Text] [Related]  

  • 39. [Results of lung resection in patients with tuberculosis in relation to the dynamics of the drug resistance at mycobacteria].
    Sveshnikova EK; Belogurova VP
    Probl Tuberk; 1967; 45(10):48-51. PubMed ID: 4979324
    [No Abstract]   [Full Text] [Related]  

  • 40. [Streptomycin and isoniazid resistance of strains of Mycobacterium tuberculosis isolated in Catania].
    Placenti A
    Lotta Tuberc; 1969; 39(4):264-74. PubMed ID: 4997375
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.